Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,778 | 5,931 | 11,526 | 16,314 | 19,373 |
| Receivables | 264 | 276 | 62 | 173 | 190 |
| Inventories | 1,034 | 857 | 600 | 189 | 111 |
| TOTAL | $21,577 | $7,718 | $12,348 | $16,951 | $19,943 |
| Non-Current Assets | |||||
| PPE Net | 924 | 791 | 755 | 558 | 598 |
| Intangibles | 5,349 | 5,556 | 5,776 | 5,970 | 6,191 |
| Other Non-Current Assets | 152 | 52 | 72 | 68 | 68 |
| TOTAL | $6,426 | $6,399 | $6,603 | $6,596 | $6,856 |
| Total Assets | $28,003 | $14,117 | $18,951 | $23,547 | $26,799 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 905 | 989 | 769 | 669 | 702 |
| Accrued Expenses | 1,010 | 1,975 | 945 | 668 | 761 |
| TOTAL | $1,916 | $2,964 | $1,714 | $1,346 | $1,463 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,916 | $2,964 | $1,714 | $1,346 | $1,463 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,046 | 2,046 | 1,589 | 1,588 | 1,587 |
| Common Shares | 4 | 3 | 3 | 3 | 3 |
| Retained earnings | -29,879 | -24,039 | -16,999 | -11,573 | -8,000 |
| Other shareholders' equity | 0 | 0 | 0 | -4,930 | -5,192 |
| TOTAL | $26,087 | $11,153 | $17,237 | $22,201 | $25,336 |
| Total Liabilities And Equity | $28,003 | $14,118 | $18,951 | $23,547 | $26,799 |